The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Decapeptyl 3-month, 11.25 mgPowder and solvent for suspension for injection



Ipsen Pharmaceuticals LimitedPA0869/003/002

Main Information

Trade NameDecapeptyl 3-month, 11.25 mgPowder and solvent for suspension for injection
Active SubstancesTriptorelin
Dosage FormPowder and solvent for suspension for injection
Licence HolderIpsen Pharmaceuticals Limited
Licence NumberPA0869/003/002

Group Information

ATC CodeL02AE Gonadotropin releasing hormone analogues
L02AE04 triptorelin

Status

License statusAuthorised
Licence Issued02/10/1998
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back